Metagen Therapeutics

Tsuruoka, Japan · Founded 2020 · Privately Held (backing)

Operator of microbiome therapeutics and manufacturing platform intended to advance precision treatment using fecal microbiota transplantation. Metagen Therapeutics is based in Tsuruoka, Japan and was founded in 2020. Its last reported valuation was $54.2 million in Jan 2026. It has raised $36.5 million.

Last reported valuation

$54.2M

Oct 2026

Priced at

—

Total raised

$36.5M

Last round

—

How much has Metagen Therapeutics raised?

$36.5Macross 0 recorded rounds

Free account

More of Metagen Therapeutics with a free account

·The complete investor list: 27 names
·Watch Metagen Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Metagen Therapeutics investors

27 investors are on record for Metagen Therapeutics, including Global Brain, SMBC Venture Capital, Mizuho Capital and J-Startup. By type, the record holds 8 venture capital firms and 1 hedge fund.

For fundraisers

Raising for a company like Metagen Therapeutics?

27 investors have backed Metagen Therapeutics.

See all 27 investors →

Frequently asked about Metagen Therapeutics

How much has Metagen Therapeutics raised?: Metagen Therapeutics has raised $36.5M in total across 0 recorded funding rounds.